Probing the links: Long non-coding RNAs and NF-κB signalling in atherosclerosis.

Area of Science:

• Cardiovascular Biology
• Molecular Medicine
• Inflammation Research

Background:

• Atherosclerosis is a chronic inflammatory condition characterized by lipid and immune cell accumulation in arteries.
• Nuclear factor kappa B (NF-kB) signaling is a critical regulator of inflammation implicated in atherosclerosis pathogenesis.
• Long non-coding RNAs (lncRNAs) are emerging as key modulators of inflammatory pathways, including NF-kB signaling.

Purpose of the Study:

• To review the current understanding of lncRNA involvement in NF-kB signaling within the context of atherosclerosis.
• To elucidate the molecular mechanisms underlying the crosstalk between lncRNAs and NF-kB in cardiovascular disease.
• To identify potential diagnostic markers and therapeutic targets for atherosclerosis based on lncRNA dysregulation.

Main Methods:

• Literature review of recent studies on lncRNAs, NF-kB signaling, and atherosclerosis.
• Analysis of experimental evidence demonstrating lncRNA influence on the NF-kB pathway.
• Synthesis of findings on altered lncRNA expression in atherosclerotic lesions.

Main Results:

• Significant alterations in specific lncRNA expression are observed in atherosclerotic lesions compared to healthy arterial tissue.
• Dysregulated lncRNAs experimentally shown to modulate NF-kB pathway activity.
• lncRNAs play a role in regulating inflammatory processes central to atherosclerosis development and progression.

Conclusions:

• The interplay between lncRNAs and NF-kB signaling is a crucial determinant of atherosclerosis.
• Targeting lncRNAs involved in NF-kB regulation offers promising therapeutic strategies for atherosclerosis.
• Further research into lncRNA-NF-kB interactions can lead to novel diagnostic and management approaches for this prevalent cardiovascular disease.